Fredun Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Fredun Pharma	Wanbury	Anuh Pharma
Operational Metrics
Financials
5 yr Average ROE	11.84 %	-11.27 %	15.87 %
5yr average Equity Multiplier	2.85	-1.35	1.62
5yr Average Asset Turnover Ratio	1.08	1.54	1.35
5yr Avg Net Profit Margin	3.9 %	5.09 %	7.23 %
Price to Book	5.22	13.73	2.43
P/E	41.59	18.93	20.49
5yr Avg Cash Conversion Cycle	175.29 Days	-103.0 Days	42.81 Days
Inventory Days	146.68 Days	21.96 Days	50.87 Days
Days Receivable	142.46 Days	61.39 Days	111.12 Days
Days Payable	112.95 Days	194.51 Days	117.6 Days
5yr Average Interest Coverage Ratio	2.62	2.13	48.66
5yr Avg ROCE	22.71 %	-37.9 %	21.17 %
5yr Avg Operating Profit Margin	9.7 %	7.72 %	10.21 %
5 yr average Debt to Equity	0.93	0.2	0.02
5yr CAGR Net Profit	25.5 %	n/a	10.73 %
5yr Average Return on Assets	4.18 %	7.92 %	9.84 %
Shareholdings
Promoter Holding	48.93 %	39.63 %	71.82 %
Share Pledged by Promoters	0.0	71.73 %	0.0
Change in Promoter Holding (3 Yrs)	-2.11 %	-0.22 %	1.23 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Fredun Pharma	Wanbury	Anuh Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 API`s & Formulation 0 Bulk drug and Chemicals 0	Product Wise Break-Up Bulk drug and Chemicals 0 API`s & Formulation 0 Pharmaceutical 0 Others 100	Product Wise Break-Up Bulk drug and Chemicals 100.0 API`s & Formulation 0 Pharmaceutical 0
Location Wise Break-Up	Location Wise Break-Up India 83.13 Rest of the World 16.86 Others 0.01	Location Wise Break-Up Rest of the World 0 India 30.27 Others 69.73	Location Wise Break-Up Rest of the World 0 India 45.02 Others 54.98